Production (Stage)
Zai Lab Limited
ZLAB
$31.32
-$1.18-3.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.19% | 65.68% | 47.72% | 45.95% | 38.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.19% | 65.68% | 47.72% | 45.95% | 38.78% |
| Cost of Revenue | 12.59% | -11.98% | 22.14% | 54.67% | 26.44% |
| Gross Profit | 737.76% | 135.61% | 95.78% | 33.89% | 84.10% |
| SG&A Expenses | -8.34% | -0.01% | -1.94% | 17.36% | 10.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.39% | -6.77% | 11.34% | 4.87% | 19.00% |
| Operating Income | 19.91% | 45.24% | 18.81% | 23.55% | -1.13% |
| Income Before Tax | 9.41% | 14.40% | 39.74% | 33.60% | -8.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.41% | 14.40% | 39.74% | 33.60% | -8.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.41% | 14.40% | 39.74% | 33.60% | -8.80% |
| EBIT | 19.91% | 45.24% | 18.81% | 23.55% | -1.13% |
| EBITDA | 21.46% | 46.63% | 20.42% | 25.01% | -0.65% |
| EPS Basic | 18.43% | 19.11% | 40.53% | 34.35% | -7.51% |
| Normalized Basic EPS | 28.23% | 22.97% | 41.30% | 46.23% | -16.29% |
| EPS Diluted | 18.43% | 19.11% | 40.53% | 34.35% | -7.51% |
| Normalized Diluted EPS | 28.23% | 22.97% | 41.30% | 46.23% | -16.29% |
| Average Basic Shares Outstanding | 11.07% | 5.81% | 1.33% | 1.15% | 1.22% |
| Average Diluted Shares Outstanding | 11.07% | 5.81% | 1.33% | 1.15% | 1.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |